Skip to content

Insertion of an Intrauterine Device (IUD) After Medical Abortion

Insertion of an IUD After Medical Abortion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00621543
Enrollment
120
Registered
2008-02-22
Start date
2006-03-31
Completion date
2008-09-30
Last updated
2011-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induced Abortion, Intrauterine Device Expulsion, Medical Abortion

Keywords

Intrauterine Device, Induced Abortion, Medical Abortion

Brief summary

The purpose of this study is to determine the expulsion and continuation rate of an intruterine device (IUD) placed immediately after medical abortion. Our hypothesis is that immediate-placement of an IUD after completed medical abortion will have a similar expulsion and continuation rate to traditional placement (4-6 weeks after pregnancy).

Detailed description

Women who seek abortion care often desire more effective or longer- lasting contraception. Intrauterine devices are as efficacious as tubal ligation, require no on-going effort on the woman's part to protect her from pregnancy, and are underutilized in the US. We are interested in determining whether placement of an intreatuereine device (IUD) at the time of confirming the completion of a medical abortion may have similar expulsion and continuation rates as IUDs placed after pregnancy (usually a 4-6 week time period). If this is the case, women may save the time and effort of yet another clinic visit, as well as have immediate protection against pregnancy after their abortion. FDA labeling does not specify or restrict time of insertion and therefore this study is in compliance with FDA labeling.

Interventions

DEVICEIUD insertion [Copper T-380A or Levonorgestrel (intrauterine system) IUS]

When a subject has chosen a method of intra-uterine contraception and has agreed to participate in the study, she will have the intra-uterine device of her choice inserted according to the Food and Druga Administration (FDA) instructions.

Sponsors

University of Utah
CollaboratorOTHER
Boston University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Women who completed a medical abortion in the last 14 days * At least 18 years old. * Desiring long-term contraception with an IUD. * Able and willing to give consent for participation in research. * Gonorrhea and chlamydia screen negative within 60 days of entry to study. * Willing to comply with the study requirements. * Accessible by telephone.

Exclusion criteria

* Had pelvic inflammatory disease or a septic abortion within the past 3 months or gonorrheal or chlamydial infection in the last 60 days. * Allergy to copper, or Wilson's disease (for Paragard; may have Mirena) * Intracavitary of symptomatic uterine fibroids. * Ovarian, cervical or endometrial cancer. * Severe anemia (defined as hgb \< 8).

Design outcomes

Primary

MeasureTime frame
Percentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion.Three months

Secondary

MeasureTime frame
Percentage of Women Continuing IUD Use at 3 Months3 months

Countries

United States

Participant flow

Participants by arm

ArmCount
Observation- All Subjects
Women choosing intra-uterine contraception after medical abortion.
120
Total120

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up23

Baseline characteristics

CharacteristicObservation- All Subjects
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
120 Participants
Age Continuous28 years
STANDARD_DEVIATION 4
Region of Enrollment
United States
120 participants
Sex: Female, Male
Female
120 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 118
serious
Total, serious adverse events
0 / 118

Outcome results

Primary

Percentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion.

Time frame: Three months

ArmMeasureValue (MEAN)
Single Arm StudyPercentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion.4 percentage of participants
Secondary

Percentage of Women Continuing IUD Use at 3 Months

Time frame: 3 months

ArmMeasureValue (MEAN)
Single Arm StudyPercentage of Women Continuing IUD Use at 3 Months80. percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026